German Firms Spend More in US Than at Home, Says VCI

In another communication expressing its growing frustration with the lack of clarity as to the energy policy of the new German federal government still being negotiated, the chemical industry association Verband der Chemischen Industrie (VCI) has published figures suggesting that German chemical firms are investing increasingly abroad, where energy is cheaper.

The association said foreign fixed investments by German chemical companies rose by around 25% in 2012 to €7.7 billion, while domestic capital spending stagnated at €6.3 billion. For the first time since 2001, it noted, foreign investments by German chemical company were higher than at home.

Much of German chemical producers' capital spending is apparently being shifted to the U.S. Over the past three years, the companies spent €6.5 billion on building new plants there or expanding existing facilities, said VCI. Spending in 2012 rose 54% to around €3.2 billion.

The fact that over 41% (compared with only 28% in 2005) of German chemical investment abroad now is earmarked for the U.S. underlines the renewed attractiveness of the country as a location for business, said VCI. It attributes the increased interest to the start of the shale gas boom in 2009. At present, electricity prices are two and a half times higher than in the U.S., gas prices three times higher, the association believes.

Cost increases for energy in Germany "put our companies under strong pressure," said VCI's general manager Utz Tillmann, calling on the German political sector to make the country's move away from nuclear power and toward renewable resources "affordable."

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.